{
  "compound_id": "DB04911",
  "compound_name": "Oritavancin",
  "compound_percentile": 0.213235294117647,
  "disease_id": "DOID:2531",
  "disease_name": "hematologic cancer",
  "disease_percentile": 0.167750325097529,
  "metapath_contribution": {
    "CcSEcCtD": 1.0
  },
  "n_trials": 0.0,
  "prediction": 0.0011750871922669999,
  "status": 0
}